Figure 3
DLBCL patients with TP53 mutations in the LSH, L2, and L3 motifs of the DNA binding domain have significantly inferior OS and PFS compared with DLBCL patients with WT-TP53.
DLBCL patients with TP53 mutations in the LSH, L2, and L3 motifs of the DNA binding domain have significantly inferior OS and PFS compared with DLBCL patients with WT-TP53.
